甘李药业：多位股东已累计减持0.58%股份

Summary of Key Points Core Viewpoint - Gannee Pharmaceutical (603087) announced that its controlling shareholder, actual controller, and concerted parties have completed their respective share reduction plans [1] Group 1: Share Reduction Details - The controlling shareholder, Xutong Hongda, reduced its holdings by 3.3995 million shares, accounting for 0.57% of the company's total share capital, with a total reduction amount of 211 million yuan [1] - Director Jiao Jiao reduced her holdings by 67,500 shares, representing 0.0112% of the company's total share capital, with a total reduction amount of 4.1631 million yuan [1]